Alcentra Capital (NASDAQ:ABDC) reported it Q3 2019, which we expect is its last quarter as a public company. It is in the process of being purchased by Crescent Capital BDC for $11.02 per share (the ...
After months of pursing a strategic review looking for alternatives to increase the company’s value, management has struck a deal to sell it. Today Crescent Capital BDC and Alcentra Capital (ABDC) ...